Page last updated: 2024-09-04

gw420867x and Headache

gw420867x has been researched along with Headache in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cass, LM; Dallow, NS; Jones, AE; Moore, KH; Prince, WT; Sisson, JR1

Trials

1 trial(s) available for gw420867x and Headache

ArticleYear
The bioavailability of the novel nonnucleoside reverse transcriptase inhibitor GW420867X is unaffected by food in healthy male volunteers.
    Journal of clinical pharmacology, 2001, Volume: 41, Issue:5

    Topics: Adult; Area Under Curve; Biological Availability; Confidence Intervals; Cross-Over Studies; Dietary Fats; Food-Drug Interactions; Gastrointestinal Diseases; Half-Life; Headache; Humans; Least-Squares Analysis; Male; Metabolic Clearance Rate; Middle Aged; Quinoxalines; Reverse Transcriptase Inhibitors

2001